Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP3K11 | Q16584 | 1/20 | 0.43 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.34 |
| ▸ | PDE4A | P27815 | 2/20 | 0.33 |
| ▸ | PDE4B | Q07343 | 2/20 | 0.33 |
| ▸ | PDE4C | Q08493 | 2/20 | 0.33 |
| ▸ | PDE4D | Q08499 | 2/20 | 0.33 |
| ▸ | PDE3B | Q13370 | 2/20 | 0.33 |
| ▸ | PDE3A | Q14432 | 2/20 | 0.33 |
| ▸ | PGR | P06401 | 2/20 | 0.33 |
| ▸ | SPR | P35270 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30748975 | 0.97 | MAP3K11 (0.46) | MAP3K11MAPK14PDE4APDE4BPDE4C | |
| SCHEMBL30749023 | 0.95 | MAP3K11 (0.45) | MAP3K11MAPK14PDE4APDE4BPDE4C | |
| SCHEMBL29388502 | 0.93 | MAP3K11 (0.39) | MAP3K11MAPK14 | |
| SCHEMBL13748469 | 0.87 | BACE1 (0.36) | MAP3K11 | |
| SCHEMBL15935920 | 0.83 | FGFR1 (0.38) | MAP3K11MAPK14 | |
| SCHEMBL17525083 | 0.74 | CRBN (0.40) | — | |
| SCHEMBL15690378 | 0.73 | MAP3K11 (0.50) | MAP3K11MAPK14PDE4APDE4BPDE4C | |
| SCHEMBL31085603 | 0.73 | — | — | |
| SCHEMBL2453230 | 0.73 | MARK3 (0.44) | MAP3K11PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL15699749 | 0.72 | CALCA (0.44) | MAP3K11PGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4565588-A1 | BIOLOGICALLY ACTIVE COMPOUNDS AND METHODS THEREOF | Suzhou Keen Therapeutics Co., Ltd. (CN) | 2025-06-11 | — | — | EP | disclosed |
| WO-2023241620-A1 | BIOLOGICALLY ACTIVE COMPOUNDS AND METHODS THEREOF | SUZHOU KEEN THERAPEUTICS CO., LTD. (CN) | 2023-12-21 | — | — | WO | disclosed |